Brief: Infant Bacterial Therapeutics Starts Listing On Nasdaq Stockholm Main Market On Sept 10
Aug 30 (Reuters) - Infant Bacterial Therapeutics AB IBTb.ST :
* REG-INFANT BACTERIAL THERAPEUTICS HAS BEEN APPROVED FOR LISTING ON THE MAIN MARKET OF
NASDAQ
STOCKHOLM
* LAST DAY OF TRADING ON NASDAQ FIRST NORTH PREMIER IS SCHEDULED FOR SEPTEMBER 7, 2018
* FIRST DAY OF TRADING ON NASDAQ STOCKHOLM IS SCHEDULED FOR SEPTEMBER 10, 2018
Source text for Eikon: ID:nGNE68CxWN
Further company coverage: IBTb.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Infant Bacterial Therapeutics AB
See all newsBrief: Infant Bacterial Therapeutics Gets FDA Request For Type B Pre-BLA Meeting
Brief: Infant Bacterial Therapeutics Q2 Operating Loss Widens To SEK 30.1 Mln
Brief: Infant Bacterial Therapeutics CFO Leaves The Company
Brief: Infant Bacterial Announces Phase III IBP-9414 Study Results
Brief: Infant Bacterial Therapeutics Q4 Operating Loss SEK 20.5 Mln